Large Animals Drugs - Global 麻豆原创 Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Publication ID:

PB509244547

Publication Date:

September 16, 2024

Pages:

136

Publisher:

MRRPB5

Countries:

Global [1]

USD 3,950.00

Healthcare [2]

Pharma & Healthcare [3]

Description:

The global market for Large Animals Drugs was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
Pet medical care is the second largest segment in pet industry. In the UK, annual spending on veterinary and other pet services has risen from 拢2.6bn in 2015 to 拢4bn in 2021, a 54% increase in just six years. According to Vetnosis, the value of the global animal health industry will increase by 12% to $38.3 billion in 2021. White Paper on China's Pet Healthy Consumption of JD shows that in 2023, there are 13.09 million pets entering middle age and old age. And pet aging is expected to be seen in the next few years. Changes in the age structure of pets will further bring about the development of the pet medical industry. According to the data of the 2022 China Pet Medical Industry White Paper, from the perspective of market size, the scale of China's pet medical market is about 楼67.5 billion, accounting for about 22.5% of the entire pet industry. From the perspective of hospital operation time, pet hospitals within 5 years accounted for about 73%. About 11% of the pet hospitals have been in operation for more than 10 years. From the perspective of hospital turnover, nearly 40% of the hospitals have increased their annual turnover year-on-year, and the growth rate is mainly within 25%.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Large Animals Drugs, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Large Animals Drugs by region & country, by Type, and by Application.
The Large Animals Drugs market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Large Animals Drugs.
麻豆原创 Segmentation
By Company
Boehringer Ingelheim
Zoetis
IDEXX Laboratories
Elanco Animal Health
Bayer Animal Health
Merck Animal Health
Dechra Veterinary Products
Parnell
Abaxis
Virbac
Ceva
Meiji
Vetoquinol
Ouro Fino Saude
Animalcare Group
IDvet
Shenzhen Mindray Bio-Medical
Bio-Rad Laboratories
Segment by Type:
Molecular Diagnostics
Immunodiagnostics
Segment by Application
Veterinary Hospitals
Veterinary Clinics
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Large Animals Drugs manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Large Animals Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Large Animals Drugs in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 麻豆原创 Overview
1.1 Large Animals Drugs Product Introduction
1.2 Global Large Animals Drugs 麻豆原创 Size Forecast
1.3 Large Animals Drugs 麻豆原创 Trends & Drivers
1.3.1 Large Animals Drugs Industry Trends
1.3.2 Large Animals Drugs 麻豆原创 Drivers & Opportunity
1.3.3 Large Animals Drugs 麻豆原创 Challenges
1.3.4 Large Animals Drugs 麻豆原创 Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Large Animals Drugs Players Revenue Ranking (2023)
2.2 Global Large Animals Drugs Revenue by Company (2019-2024)
2.3 Key Companies Large Animals Drugs Manufacturing Base Distribution and Headquarters
2.4 Key Companies Large Animals Drugs Product Offered
2.5 Key Companies Time to Begin Mass Production of Large Animals Drugs
2.6 Large Animals Drugs 麻豆原创 Competitive Analysis
2.6.1 Large Animals Drugs 麻豆原创 Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Large Animals Drugs Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Large Animals Drugs as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Molecular Diagnostics
3.1.2 Immunodiagnostics
3.2 Global Large Animals Drugs Sales Value by Type
3.2.1 Global Large Animals Drugs Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Large Animals Drugs Sales Value, by Type (2019-2030)
3.2.3 Global Large Animals Drugs Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Veterinary Hospitals
4.1.2 Veterinary Clinics
4.1.3 Others
4.2 Global Large Animals Drugs Sales Value by Application
4.2.1 Global Large Animals Drugs Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Large Animals Drugs Sales Value, by Application (2019-2030)
4.2.3 Global Large Animals Drugs Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Large Animals Drugs Sales Value by Region
5.1.1 Global Large Animals Drugs Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Large Animals Drugs Sales Value by Region (2019-2024)
5.1.3 Global Large Animals Drugs Sales Value by Region (2025-2030)
5.1.4 Global Large Animals Drugs Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Large Animals Drugs Sales Value, 2019-2030
5.2.2 North America Large Animals Drugs Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Large Animals Drugs Sales Value, 2019-2030
5.3.2 Europe Large Animals Drugs Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Large Animals Drugs Sales Value, 2019-2030
5.4.2 Asia Pacific Large Animals Drugs Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Large Animals Drugs Sales Value, 2019-2030
5.5.2 South America Large Animals Drugs Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Large Animals Drugs Sales Value, 2019-2030
5.6.2 Middle East & Africa Large Animals Drugs Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Large Animals Drugs Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Large Animals Drugs Sales Value
6.3 United States
6.3.1 United States Large Animals Drugs Sales Value, 2019-2030
6.3.2 United States Large Animals Drugs Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Large Animals Drugs Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Large Animals Drugs Sales Value, 2019-2030
6.4.2 Europe Large Animals Drugs Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Large Animals Drugs Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Large Animals Drugs Sales Value, 2019-2030
6.5.2 China Large Animals Drugs Sales Value by Type (%), 2023 VS 2030
6.5.3 China Large Animals Drugs Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Large Animals Drugs Sales Value, 2019-2030
6.6.2 Japan Large Animals Drugs Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Large Animals Drugs Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Large Animals Drugs Sales Value, 2019-2030
6.7.2 South Korea Large Animals Drugs Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Large Animals Drugs Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Large Animals Drugs Sales Value, 2019-2030
6.8.2 Southeast Asia Large Animals Drugs Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Large Animals Drugs Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Large Animals Drugs Sales Value, 2019-2030
6.9.2 India Large Animals Drugs Sales Value by Type (%), 2023 VS 2030
6.9.3 India Large Animals Drugs Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Boehringer Ingelheim
7.1.1 Boehringer Ingelheim Profile
7.1.2 Boehringer Ingelheim Main Business
7.1.3 Boehringer Ingelheim Large Animals Drugs Products, Services and Solutions
7.1.4 Boehringer Ingelheim Large Animals Drugs Revenue (US$ Million) & (2019-2024)
7.1.5 Boehringer Ingelheim Recent Developments
7.2 Zoetis
7.2.1 Zoetis Profile
7.2.2 Zoetis Main Business
7.2.3 Zoetis Large Animals Drugs Products, Services and Solutions
7.2.4 Zoetis Large Animals Drugs Revenue (US$ Million) & (2019-2024)
7.2.5 Zoetis Recent Developments
7.3 IDEXX Laboratories
7.3.1 IDEXX Laboratories Profile
7.3.2 IDEXX Laboratories Main Business
7.3.3 IDEXX Laboratories Large Animals Drugs Products, Services and Solutions
7.3.4 IDEXX Laboratories Large Animals Drugs Revenue (US$ Million) & (2019-2024)
7.3.5 Elanco Animal Health Recent Developments
7.4 Elanco Animal Health
7.4.1 Elanco Animal Health Profile
7.4.2 Elanco Animal Health Main Business
7.4.3 Elanco Animal Health Large Animals Drugs Products, Services and Solutions
7.4.4 Elanco Animal Health Large Animals Drugs Revenue (US$ Million) & (2019-2024)
7.4.5 Elanco Animal Health Recent Developments
7.5 Bayer Animal Health
7.5.1 Bayer Animal Health Profile
7.5.2 Bayer Animal Health Main Business
7.5.3 Bayer Animal Health Large Animals Drugs Products, Services and Solutions
7.5.4 Bayer Animal Health Large Animals Drugs Revenue (US$ Million) & (2019-2024)
7.5.5 Bayer Animal Health Recent Developments
7.6 Merck Animal Health
7.6.1 Merck Animal Health Profile
7.6.2 Merck Animal Health Main Business
7.6.3 Merck Animal Health Large Animals Drugs Products, Services and Solutions
7.6.4 Merck Animal Health Large Animals Drugs Revenue (US$ Million) & (2019-2024)
7.6.5 Merck Animal Health Recent Developments
7.7 Dechra Veterinary Products
7.7.1 Dechra Veterinary Products Profile
7.7.2 Dechra Veterinary Products Main Business
7.7.3 Dechra Veterinary Products Large Animals Drugs Products, Services and Solutions
7.7.4 Dechra Veterinary Products Large Animals Drugs Revenue (US$ Million) & (2019-2024)
7.7.5 Dechra Veterinary Products Recent Developments
7.8 Parnell
7.8.1 Parnell Profile
7.8.2 Parnell Main Business
7.8.3 Parnell Large Animals Drugs Products, Services and Solutions
7.8.4 Parnell Large Animals Drugs Revenue (US$ Million) & (2019-2024)
7.8.5 Parnell Recent Developments
7.9 Abaxis
7.9.1 Abaxis Profile
7.9.2 Abaxis Main Business
7.9.3 Abaxis Large Animals Drugs Products, Services and Solutions
7.9.4 Abaxis Large Animals Drugs Revenue (US$ Million) & (2019-2024)
7.9.5 Abaxis Recent Developments
7.10 Virbac
7.10.1 Virbac Profile
7.10.2 Virbac Main Business
7.10.3 Virbac Large Animals Drugs Products, Services and Solutions
7.10.4 Virbac Large Animals Drugs Revenue (US$ Million) & (2019-2024)
7.10.5 Virbac Recent Developments
7.11 Ceva
7.11.1 Ceva Profile
7.11.2 Ceva Main Business
7.11.3 Ceva Large Animals Drugs Products, Services and Solutions
7.11.4 Ceva Large Animals Drugs Revenue (US$ Million) & (2019-2024)
7.11.5 Ceva Recent Developments
7.12 Meiji
7.12.1 Meiji Profile
7.12.2 Meiji Main Business
7.12.3 Meiji Large Animals Drugs Products, Services and Solutions
7.12.4 Meiji Large Animals Drugs Revenue (US$ Million) & (2019-2024)
7.12.5 Meiji Recent Developments
7.13 Vetoquinol
7.13.1 Vetoquinol Profile
7.13.2 Vetoquinol Main Business
7.13.3 Vetoquinol Large Animals Drugs Products, Services and Solutions
7.13.4 Vetoquinol Large Animals Drugs Revenue (US$ Million) & (2019-2024)
7.13.5 Vetoquinol Recent Developments
7.14 Ouro Fino Saude
7.14.1 Ouro Fino Saude Profile
7.14.2 Ouro Fino Saude Main Business
7.14.3 Ouro Fino Saude Large Animals Drugs Products, Services and Solutions
7.14.4 Ouro Fino Saude Large Animals Drugs Revenue (US$ Million) & (2019-2024)
7.14.5 Ouro Fino Saude Recent Developments
7.15 Animalcare Group
7.15.1 Animalcare Group Profile
7.15.2 Animalcare Group Main Business
7.15.3 Animalcare Group Large Animals Drugs Products, Services and Solutions
7.15.4 Animalcare Group Large Animals Drugs Revenue (US$ Million) & (2019-2024)
7.15.5 Animalcare Group Recent Developments
7.16 IDvet
7.16.1 IDvet Profile
7.16.2 IDvet Main Business
7.16.3 IDvet Large Animals Drugs Products, Services and Solutions
7.16.4 IDvet Large Animals Drugs Revenue (US$ Million) & (2019-2024)
7.16.5 IDvet Recent Developments
7.17 Shenzhen Mindray Bio-Medical
7.17.1 Shenzhen Mindray Bio-Medical Profile
7.17.2 Shenzhen Mindray Bio-Medical Main Business
7.17.3 Shenzhen Mindray Bio-Medical Large Animals Drugs Products, Services and Solutions
7.17.4 Shenzhen Mindray Bio-Medical Large Animals Drugs Revenue (US$ Million) & (2019-2024)
7.17.5 Shenzhen Mindray Bio-Medical Recent Developments
7.18 Bio-Rad Laboratories
7.18.1 Bio-Rad Laboratories Profile
7.18.2 Bio-Rad Laboratories Main Business
7.18.3 Bio-Rad Laboratories Large Animals Drugs Products, Services and Solutions
7.18.4 Bio-Rad Laboratories Large Animals Drugs Revenue (US$ Million) & (2019-2024)
7.18.5 Bio-Rad Laboratories Recent Developments
8 Industry Chain Analysis
8.1 Large Animals Drugs Industrial Chain
8.2 Large Animals Drugs Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Large Animals Drugs Sales Model
8.5.2 Sales Channel
8.5.3 Large Animals Drugs Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer

Companies Mentioned:

Boehringer Ingelheim
Zoetis
IDEXX Laboratories
Elanco Animal Health
Bayer Animal Health
Merck Animal Health
Dechra Veterinary Products
Parnell
Abaxis
Virbac
Ceva
Meiji
Vetoquinol
Ouro Fino Saude
Animalcare Group
IDvet
Shenzhen Mindray Bio-Medical
Bio-Rad Laboratories

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.